Clinic
Commonwealth Health Corporation, INC.
Commonwealth Health Corporation, INC. was paid $1.82M by Medicaid between Jan 2018 and Dec 2024, across 41 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 27% of everything it billed.
33Billing provider infoCOMMONWEALTH HEALTH CORPORATION, INC.
BOWLING GREEN, KY 42103
BOWLING GREEN, KY 42103
33aNPI1821478975assigned 06/04/2015
33bProvider typeCorporate Health Clinic/Center
28Total paid$1.82M
24GClaims89,902
24DCodes billed41
24AFirst – last monthJan 2018 – Dec 2024
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official LAWLESS, MICHELE controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,298 | $89K | |
| 2019 | 3,508 | $157K | |
| 2020 | 8,772 | $221K | |
| 2021 | 10,648 | $293K | |
| 2022 | 17,701 | $356K | |
| 2023 | 25,668 | $389K | |
| 2024incomplete | 21,307 | $318K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 27% | 17,115 | 14,326 | $490K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 21% | 5,389 | 4,362 | $378K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 14% | 7,650 | 6,013 | $251K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 10% | 6,768 | 5,674 | $190K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 8.2% | 3,322 | 2,877 | $149K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 7.5% | 10,144 | 8,801 | $137K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 3.8% | 762 | 598 | $70K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 3.6% | 1,317 | 1,085 | $65K |
| 0002A | <1% | 497 | 486 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,366 | 1,118 | $17K |
| 0001A | <1% | 463 | 444 | $17K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 480 | 457 | $8K |
29 more codes
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 85 | $6K |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 641 | $5K |
| 0003A | <1% | 169 | $4K | |
| 0054A | <1% | 113 | $3K | |
| 0004A | <1% | 173 | $3K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 77 | $3K |
| 87807 | <1% | 248 | $2K | |
| 0071A | <1% | 63 | $2K | |
| 0124A | <1% | 105 | $2K | |
| 0072A | <1% | 31 | $1K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 38 | $1K |
| 90686 | <1% | 40 | $778.50 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 14 | $316.38 |
| 90656 | <1% | 12 | $267.85 | |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $144.85 |
| 81003 | <1% | 102 | $46.23 | |
| 3074F | <1% | 8,548 | $17.96 | |
| 3078F | <1% | 7,010 | $12.48 | |
| 3079F | <1% | 2,973 | $8.44 | |
| 1125F | <1% | 1,347 | $4.43 | |
| 3075F | <1% | 610 | $1.30 | |
| 3077F | <1% | 420 | $1.11 | |
| 1159F | <1% | 2,920 | $1.09 | |
| 3008F | <1% | 4,041 | $0.42 | |
| 1036F | <1% | 3,416 | $0.29 | |
| 0521F | <1% | 724 | $0.27 | |
| 3080F | <1% | 93 | $0.22 | |
| 1160F | <1% | 188 | $0.10 | |
| 1034F | <1% | 415 | $0.08 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLAWLESS, MICHELE (EXECUTIVE VICE PRESIDENT)
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.